Methylene Blue is Associated With Poor Outcomes in Vasoplegic Shock
The current study identified the use of methylene blue as treatment for vasoplegia to be independently associated with poor outcomes.
You may also like
AmSECT’s Strategic Plan 2014-2016 (EP Video)
New AmSECT president Jeffrey Riley present his strategic plan for AmSECT (29:626 Minutes).
1 min read
Impact of Permissive Hypercapnia on Regional Cerebral Oxygen Saturation and Postoperative Cognitive Function in Patients Undergoing Cardiac Valve Replacement
PHC can increase the rSO2 of patients undergoing CVR, increase cerebral blood flow, improve the cerebral oxygen supply/consumption balance, and play a protective role in the brain. It has no significant impact on the incidence of POCD.
1 min read